Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
European Neurology
|
January 1, 1993
Long-term experience with sumatriptan in the treatment of migraine
M J Tansey, A J Pilgrim, P M Martin
BMJ (Clinical Research Ed.)
|
August 1, 1992
Coronary vasospasm and sumatriptan
D K Lloyd, A J Pilgrim, V E Simmons
British Journal of Clinical Pharmacology
|
December 1, 1990
A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers
G R McClelland, S M Cooper, A J Pilgrim
Drug Safety
|
October 8, 1999
Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events
L A Harker, J P Boissel, A J Pilgrim, et al.
Neurology
|
August 1, 1996
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine
J Touchon, L Bertin, A J Pilgrim, et al.
Acta Neurologica Scandinavica
|
July 1, 1993
Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group
K Ekbom, I Monstad, A Prusinski, et al.
Cephalalgia : an International Journal of Headache
|
October 1, 1992
Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group
W H Visser, M D Ferrari, E M Bayliss, et al.
British Journal of Clinical Pharmacology
|
April 1, 1992
Sumatriptan and cerebral perfusion in healthy volunteers
A K Scott, S Grimes, K Ng, et al.
Cephalalgia : an International Journal of Headache
|
August 1, 1994
A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice
M B Russell, O E Holm-Thomsen, M Rishøj Nielsen, et al.
Ugeskrift for Laeger
|
April 17, 1995
[Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study]
M B Russell, O E Holm-Thomsen, M R Nielsen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
European Neurology
|
January 1, 1993
Long-term experience with sumatriptan in the treatment of migraine
M J Tansey, A J Pilgrim, P M Martin
BMJ (Clinical Research Ed.)
|
August 1, 1992
Coronary vasospasm and sumatriptan
D K Lloyd, A J Pilgrim, V E Simmons
British Journal of Clinical Pharmacology
|
December 1, 1990
A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers
G R McClelland, S M Cooper, A J Pilgrim
Drug Safety
|
October 8, 1999
Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events
L A Harker, J P Boissel, A J Pilgrim, et al.
Neurology
|
August 1, 1996
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine
J Touchon, L Bertin, A J Pilgrim, et al.
Acta Neurologica Scandinavica
|
July 1, 1993
Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group
K Ekbom, I Monstad, A Prusinski, et al.
Cephalalgia : an International Journal of Headache
|
October 1, 1992
Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group
W H Visser, M D Ferrari, E M Bayliss, et al.
British Journal of Clinical Pharmacology
|
April 1, 1992
Sumatriptan and cerebral perfusion in healthy volunteers
A K Scott, S Grimes, K Ng, et al.
Cephalalgia : an International Journal of Headache
|
August 1, 1994
A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice
M B Russell, O E Holm-Thomsen, M Rishøj Nielsen, et al.
Ugeskrift for Laeger
|
April 17, 1995
[Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study]
M B Russell, O E Holm-Thomsen, M R Nielsen, et al.
Page
of 3